Rohrabacher's Leadership Promises to Strengthen Intellectual Property Protection and Innovation WASHINGTON, D.C., WASHINGTON, D.C. / ACCESS ...
Opinion
2dOpinion
This isn't an anti-AI lawsuit or an effort to turn back the clock. Artificial intelligence will help us, but only if it respects intellectual property ...
MELVILLE, N.Y., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions, is proud to announce that the vast majority* of lenses utilized on the FOX live broadcast ...
Certis Oncology Solutions, a precision oncology and translational science company, announced today that the United States ...
Schrödinger will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets close. The company will host a conference call and webcast ...
In conjunction with National Inventors Day today, the National Inventors Hall of Fame® is proud to recognize 17 innovation pioneers, whose inventions range from cancer treatments to satellite-based ...
Eton has secured a patent from the USPTO for its ET-600 product candidate’s desmopressin oral solution formulation for ...
Mr. Shah Coherent Market Insights Pvt. Ltd. +1 2524771362 email us here Visit us on social media: Facebook X LinkedIn ...
Mr. Shah Coherent Market Insights Pvt. Ltd. +1 2524771362 email us here Visit us on social media: Facebook X LinkedIn ...
AI innovations and governments’ preferences can make international consensus on governance at the Paris Summit challenging.
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback